KIWOOM ASSET MANAGEMENT CO LTD KIWOOM US BLOCKBUSTER BIOTEKIWOOM ASSET MANAGEMENT CO LTD KIWOOM US BLOCKBUSTER BIOTEKIWOOM ASSET MANAGEMENT CO LTD KIWOOM US BLOCKBUSTER BIOTE

KIWOOM ASSET MANAGEMENT CO LTD KIWOOM US BLOCKBUSTER BIOTE

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪4.51 B‬KRW
Fund flows (1Y)
‪−5.60 B‬KRW
Dividend yield (indicated)
1.64%
Discount/Premium to NAV
0.1%
Shares outstanding
‪500.00 K‬
Expense ratio
0.49%

About KIWOOM ASSET MANAGEMENT CO LTD KIWOOM US BLOCKBUSTER BIOTE


Brand
Kiwoom
Home page
Inception date
May 28, 2024
Index tracked
Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
Kiwoom Asset Management Co., Ltd.
ISIN
KR7483030003

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Vanilla
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of July 31, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks90.64%
Health Technology90.64%
Bonds, Cash & Other9.36%
Cash9.36%
Stock breakdown by region
63%34%2%
North America63.36%
Europe34.06%
Asia2.58%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


483030 last dividends amounted to 145.00 KRW. Before that, the issuer paid 40.00 KRW in dividends, which shows a 72.41% increase.
483030 assets under management is ‪4.51 B‬ KRW. It's risen 45.00% over the last month.
483030 fund flows account for ‪−5.60 B‬ KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, 483030 pays dividends to its holders with the dividend yield of 1.64%. The last dividend (Aug 4, 2025) amounted to 145.00 KRW.
483030 shares are issued by KIWOOM Securities Co., Ltd. under the brand Kiwoom. The ETF was launched on May 28, 2024, and its management style is Passive.
483030 expense ratio is 0.49% meaning you'd have to pay 0.49% of your investment to help manage the fund.
483030 follows the Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
483030 invests in stocks.
483030 price has fallen by −2.96% over the last month, and its yearly performance shows a −14.81% decrease. See more dynamics on 483030 price chart.
NAV returns, another gauge of an ETF dynamics, showed a −3.15% decrease in three-month performance and has decreased by −8.18% in a year.
483030 trades at a premium (0.11%) meaning the ETF is trading at a higher price than the calculated NAV.